Anteris Technologies Global Corp. Files Q1 2025 10-Q

Ticker: AVR · Form: 10-Q · Filed: May 13, 2025 · CIK: 2011514

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

TL;DR

Anteris Tech filed its Q1 2025 10-Q. Standard quarterly update.

AI Summary

Anteris Technologies Global Corp. filed its quarterly report for the period ending March 31, 2025. The company, incorporated in Delaware, is involved in the orthopedic, prosthetic & surgical appliances & supplies industry. Its principal executive offices are located in Eagan, MN, with a business phone number of 651-493-0606. The filing is a Form 10-Q, indicating a routine quarterly report.

Why It Matters

This filing provides investors with an update on Anteris Technologies Global Corp.'s financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a standard quarterly filing (10-Q) and does not inherently indicate new risks.

Key Players & Entities

FAQ

What is the primary purpose of this filing?

This filing is a Form 10-Q, which is a quarterly report filed by public companies to provide a summary of their financial performance and operations for the quarter.

For what period is this report filed?

This report is for the quarterly period ended March 31, 2025.

What is Anteris Technologies Global Corp.'s Standard Industrial Classification (SIC) code?

Anteris Technologies Global Corp.'s SIC code is 3842, which corresponds to Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Where are Anteris Technologies Global Corp.'s principal executive offices located?

The principal executive offices are located at 860 Blue Gentian Road, Suite 340, Eagan, MN 55121.

What is the company's commission file number?

The commission file number for Anteris Technologies Global Corp. is 001-42437.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Anteris Technologies Global Corp. (AVR).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing